Hirayama disease prognosis
Web18 ott 2024 · Hirayama disease is a rare disease of the nervous system presenting with weakness of one or both hands. This condition was first described by Keizo Hirayama in 1959. It is also called as... Web1 feb 2024 · Hirayama disease (HD) is characterized by the juvenile onset of unilateral or asymmetric weakness and amyotrophy of the hand and ulnar forearm and is most common in males in Asia. A perception...
Hirayama disease prognosis
Did you know?
Web11 mag 2024 · Most cases of cervical flexion myelopathy as represented by Hirayama disease have a self-limiting benign prognosis. However, some cases can develop … Web28 ago 2016 · Hirayama disease, also known as monomelic amyotrophy (MMA), is a rare cervical myelopathy that manifests itself as a self-limited, asymmetrical, slowly …
WebMay 4-8, 2009. Kenji HIRAYAMA: The innate response critical for dengue infection. WHO/TDR Course on Immunology and Vaccinology Applied to Dengue infection. WHO/TDR Clinical Coordination and Training Center, Academic Affairs Building, Thammasat University (Rangsit Campus), Thailand, May 4-8, 2009. Web1 gen 2024 · Hirayama disease is likely associated with growth and development in puberty, and early identification, regardless of whether patients are male or female, is …
Web1 feb 2024 · Hirayama disease (HD) is characterized by the juvenile onset of unilateral or asymmetric weakness and amyotrophy of the hand and ulnar forearm and is most … Web1 dic 2024 · Hirayama K. [Juvenile non-progressive muscular atrophy localized in the hand and forearm--observations in 38 cases]. Rinsho Shinkeigaku 1972; 12:313. Pradhan S. …
Web2 ott 2024 · Hirayama disease, or monomelic amyotrophy, is an uncommon cause of distal arm weakness, clinically distinct from other motor neuron diseases as it has a benign prognosis. 1 It primarily affects adolescents with male predominance. 1 It is characterised by progressive distal upper extremity weakness and atrophy in the C7-T1 distribution, …
Web22 feb 2024 · Hirayama disease has a good prognosis, as the disease progresses slowly, so that there is ample opportunity for therapeutic intervention. Of all the … citylink melbourne arWeb15 mag 2024 · 1. Introduction. Hirayama disease is a rare neurological disease characterized by insidious unilateral or bilateral muscular atrophy and weakness of the forearms and hands, without sensory or pyramidal signs [1].The disease affects primarily young men, progresses for a mean of 4–5 years and spontaneously arrests several … citylink map melbourneWebThe fourteen cases of Hirayama disease (HD) are presented in this article. HD is seldom disease characterized by juvenile muscular atrophy of upper extremities and benign course. All cases were diagnosed in the Research Center of Neurology (Moscow, Russia) during the year 2015-2024. citylink mall singapore directoryWebWhile progression typically arrests within a few years in Hirayama disease, segmental LMN disease is a localised form of sporadic adult-onset LMN disease affecting the upper limbs characterised by progression over a longer period extending up to 20 years. 47 The clinical presentation is with asymmetrical LMN signs localised to the upper … city link melbourneWeb11 mag 2024 · Introduction: Hirayama disease, a type of cervical flexion myelopathy, is a rare neurological disease characterized by muscular atrophy of the forearms and hands. … citylink melbourne abnWeb18 mag 2024 · Although the natural history of the Hirayama disease has a self-limiting course over the long term, the weakness can progress from 1 month to 5 years. In … citylink melbourne accountWeb15 gen 2024 · The prognosis of microscopic polyangiitis (MPA) with interstitial lung disease (ILD) is significantly worse than that of MPA without ILD. However, the clinical characteristics in MPA-ILD ... citylink melbourne login